These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38358805)

  • 1. Increasing Sufu gene dosage reveals its unorthodox role in promoting polydactyly and medulloblastoma tumorigenesis.
    Han B; Wang Y; Yue S; Zhang YH; Kuang L; Gao BB; Wang Y; Zhang Z; Pu X; Wang XF; Hui CC; Yu TT; Liu C; Cheng SY
    JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38358805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional repressor REST drives lineage stage-specific chromatin compaction at
    Dobson THW; Tao RH; Swaminathan J; Maegawa S; Shaik S; Bravo-Alegria J; Sharma A; Kennis B; Yang Y; Callegari K; Haltom AR; Taylor P; Kogiso M; Qi L; Khatua S; Goldman S; Lulla RR; Fangusaro J; MacDonald TJ; Li XN; Hawkins C; Rajaram V; Gopalakrishnan V
    Sci Signal; 2019 Jan; 12(565):. PubMed ID: 30670636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Regulatory Functions of SUFU and Targetome of GLI2 in SHH Subgroup Medulloblastoma.
    Yin WC; Satkunendran T; Mo R; Morrissy S; Zhang X; Huang ES; Uusküla-Reimand L; Hou H; Son JE; Liu W; Liu YC; Zhang J; Parker J; Wang X; Farooq H; Selvadurai H; Chen X; Ngan ES; Cheng SY; Dirks PB; Angers S; Wilson MD; Taylor MD; Hui CC
    Dev Cell; 2019 Jan; 48(2):167-183.e5. PubMed ID: 30554998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of suppressor-of-fused function promotes tumorigenesis.
    Lee Y; Kawagoe R; Sasai K; Li Y; Russell HR; Curran T; McKinnon PJ
    Oncogene; 2007 Sep; 26(44):6442-7. PubMed ID: 17452975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressor of Fused Is Required for Determining Digit Number and Identity via Gli3/Fgfs/Gremlin.
    Li J; Wang Q; Cui Y; Yang X; Li Y; Zhang X; Qiu M; Zhang Z; Zhang Z
    PLoS One; 2015; 10(5):e0128006. PubMed ID: 26001200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in RNA and microRNA Expression Between PTCH1- and SUFU-mutated Medulloblastoma.
    Gershanov S; Toledano H; Pernicone N; Fichman S; Michowiz S; Pinhasov A; Goldenberg-Cohen N; Listovsky T; Salmon-Divon M
    Cancer Genomics Proteomics; 2021; 18(3):335-347. PubMed ID: 33893086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of medulloblastomas with extensive nodularity (MBEN).
    Korshunov A; Sahm F; Stichel D; Schrimpf D; Ryzhova M; Zheludkova O; Golanov A; Lichter P; Jones DTW; von Deimling A; Pfister SM; Kool M
    Acta Neuropathol; 2018 Aug; 136(2):303-313. PubMed ID: 29569031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Itch/β-arrestin2-dependent non-proteolytic ubiquitylation of SuFu controls Hedgehog signalling and medulloblastoma tumorigenesis.
    Infante P; Faedda R; Bernardi F; Bufalieri F; Lospinoso Severini L; Alfonsi R; Mazzà D; Siler M; Coni S; Po A; Petroni M; Ferretti E; Mori M; De Smaele E; Canettieri G; Capalbo C; Maroder M; Screpanti I; Kool M; Pfister SM; Guardavaccaro D; Gulino A; Di Marcotullio L
    Nat Commun; 2018 Mar; 9(1):976. PubMed ID: 29515120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ABC Transporter Drives Medulloblastoma Pathogenesis by Regulating Sonic Hedgehog Signaling.
    Wijaya J; Vo BT; Liu J; Xu B; Wu G; Wang Y; Peng J; Zhang J; Janke LJ; Orr BA; Yu J; Roussel MF; Schuetz JD
    Cancer Res; 2020 Apr; 80(7):1524-1537. PubMed ID: 31948942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
    Kool M; Jones DT; Jäger N; Northcott PA; Pugh TJ; Hovestadt V; Piro RM; Esparza LA; Markant SL; Remke M; Milde T; Bourdeaut F; Ryzhova M; Sturm D; Pfaff E; Stark S; Hutter S; Seker-Cin H; Johann P; Bender S; Schmidt C; Rausch T; Shih D; Reimand J; Sieber L; Wittmann A; Linke L; Witt H; Weber UD; Zapatka M; König R; Beroukhim R; Bergthold G; van Sluis P; Volckmann R; Koster J; Versteeg R; Schmidt S; Wolf S; Lawerenz C; Bartholomae CC; von Kalle C; Unterberg A; Herold-Mende C; Hofer S; Kulozik AE; von Deimling A; Scheurlen W; Felsberg J; Reifenberger G; Hasselblatt M; Crawford JR; Grant GA; Jabado N; Perry A; Cowdrey C; Croul S; Zadeh G; Korbel JO; Doz F; Delattre O; Bader GD; McCabe MG; Collins VP; Kieran MW; Cho YJ; Pomeroy SL; Witt O; Brors B; Taylor MD; Schüller U; Korshunov A; Eils R; Wechsler-Reya RJ; Lichter P; Pfister SM;
    Cancer Cell; 2014 Mar; 25(3):393-405. PubMed ID: 24651015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomorphic Recessive Variants in SUFU Impair the Sonic Hedgehog Pathway and Cause Joubert Syndrome with Cranio-facial and Skeletal Defects.
    De Mori R; Romani M; D'Arrigo S; Zaki MS; Lorefice E; Tardivo S; Biagini T; Stanley V; Musaev D; Fluss J; Micalizzi A; Nuovo S; Illi B; Chiapparini L; Di Marcotullio L; Issa MY; Anello D; Casella A; Ginevrino M; Leggins AS; Roosing S; Alfonsi R; Rosati J; Schot R; Mancini GMS; Bertini E; Dobyns WB; Mazza T; Gleeson JG; Valente EM
    Am J Hum Genet; 2017 Oct; 101(4):552-563. PubMed ID: 28965847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog signaling promotes the degradation of tumor suppressor Sufu through the ubiquitin-proteasome pathway.
    Yue S; Chen Y; Cheng SY
    Oncogene; 2009 Jan; 28(4):492-9. PubMed ID: 18997815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.
    Guerrini-Rousseau L; Dufour C; Varlet P; Masliah-Planchon J; Bourdeaut F; Guillaud-Bataille M; Abbas R; Bertozzi AI; Fouyssac F; Huybrechts S; Puget S; Bressac-De Paillerets B; Caron O; Sevenet N; Dimaria M; Villebasse S; Delattre O; Valteau-Couanet D; Grill J; Brugières L
    Neuro Oncol; 2018 Jul; 20(8):1122-1132. PubMed ID: 29186568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patched1 deletion increases N-Myc protein stability as a mechanism of medulloblastoma initiation and progression.
    Thomas WD; Chen J; Gao YR; Cheung B; Koach J; Sekyere E; Norris MD; Haber M; Ellis T; Wainwright B; Marshall GM
    Oncogene; 2009 Apr; 28(13):1605-15. PubMed ID: 19234491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein phosphatase 4 promotes Hedgehog signaling through dephosphorylation of Suppressor of fused.
    Liao H; Cai J; Liu C; Shen L; Pu X; Yao Y; Han B; Yu T; Cheng SY; Yue S
    Cell Death Dis; 2020 Aug; 11(8):686. PubMed ID: 32826873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sufu and Kif7 in limb patterning and development.
    Zhulyn O; Hui CC
    Dev Dyn; 2015 Mar; 244(3):468-78. PubMed ID: 25581370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor gene co-operativity in compound Patched1 and suppressor of fused heterozygous mutant mice.
    Svärd J; Rozell B; Toftgård R; Teglund S
    Mol Carcinog; 2009 May; 48(5):408-19. PubMed ID: 18781608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of Fused Chaperones Gli Proteins To Generate Transcriptional Responses to Sonic Hedgehog Signaling.
    Zhang Z; Shen L; Law K; Zhang Z; Liu X; Hua H; Li S; Huang H; Yue S; Hui CC; Cheng SY
    Mol Cell Biol; 2017 Feb; 37(3):. PubMed ID: 27849569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor of fused controls mid-hindbrain patterning and cerebellar morphogenesis via GLI3 repressor.
    Kim JJ; Gill PS; Rotin L; van Eede M; Henkelman RM; Hui CC; Rosenblum ND
    J Neurosci; 2011 Feb; 31(5):1825-36. PubMed ID: 21289193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway.
    Chen J; Lv H; Hu J; Ji M; Xue N; Li C; Ma S; Zhou Q; Lin B; Li Y; Yu S; Chen X
    Cancer Lett; 2016 Oct; 381(2):391-403. PubMed ID: 27495899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.